The development and application of genome editing technology in ruminants: a review

Abstract

Transgenic ruminants are a valuable resource for both animal breeding and biomedical research. The development of transgenic breeding is proceeding slowly, because it suffers from low efficiency of gene transfer and possible safety problems from uncontrolled random integration. However, new breeding methods combined with genome editing and somatic cell nuclear transfer or microinjection can offer an economic and efficient way to produce gene-edited ruminants, which can serve as bioreactors or have improved disease resistance, animal welfare and product quality. Recent advances in precise genome editing technologies, especially clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 nucleases, are enabling the systematic development of gene-edited ruminant production. This review covers the development of gene-edited ruminants, the particulars of site-specific engineered nucleases and the state of the art and new insights into practical applications and social acceptance of genome editing technology in ruminants. It is concluded that the production of gene-edited ruminants is feasible and through improvements in genome editing technology it is possible to help feed the world.

Keywords

bioreactors / breeding / engineered endonucleases / genome editing / ruminants

References

[1] Gao Y, Wu H, Wang Y, Liu X, Chen L, Li Q, Cui C, Liu X, Zhang J, Zhang Y. Single Cas9 nickase induced generation of NRAMP1 knockin cattle with reduced off-target effects. Genome Biology, 2017, 18(1): 13

[2] Miao X. Recent advances in the development of new transgenic animal technology. Cellular and Molecular Life Sciences, 2013, 70(5): 815–828

[3] Carlson D F, Lancto C A, Zang B, Kim E S, Walton M, Oldeschulte D, Seabury C, Sonstegard T S, Fahrenkrug S C. Production of hornless dairy cattle from genome-edited cell lines. Nature Biotechnology, 2016, 34(5): 479–481

[4] Luo J, Song Z, Yu S, Cui D, Wang B, Ding F, Li S, Dai Y, Li N. Efficient generation of myostatin (MSTN) biallelic mutations in cattle using zinc finger nucleases. PLoS One, 2014, 9(4): e95225

[5] Hammer R E, Pursel V G, Rexroad C E Jr, Wall R J, Bolt D J, Ebert K M, Palmiter R D, Brinster R L. Production of transgenic rabbits, sheep and pigs by microinjection. Nature, 1985, 315(6021): 680–683

[6] Lillico S G, Proudfoot C, Carlson D F, Stverakova D, Neil C, Blain C, King T J, Ritchie W A, Tan W, Mileham A J, McLaren D G, Fahrenkrug S C, Whitelaw C B A. Live pigs produced from genome edited zygotes. Scientific Reports, 2013, 3(1): 2847

[7] Wu H, Wang Y, Zhang Y, Yang M, Lv J, Liu J, Zhang Y. TALE nickase-mediated SP110 knockin endows cattle with increased resistance to tuberculosis. Proceedings of the National Academy of Sciences of the United States of America, 2015, 112(13): E1530–E1539

[8] Capecchi M R. How close are we to implementing gene targeting in animals other than the mouse? Proceedings of the National Academy of Sciences of the United States of America, 2000, 97(3): 956–957

[9] Baguisi A, Behboodi E, Melican D T, Pollock J S, Destrempes M M, Cammuso C, Williams J L, Nims S D, Porter C A, Midura P, Palacios M J, Ayres S L, Denniston R S, Hayes M L, Ziomek C A, Meade H M, Godke R A, Gavin W G, Overström E W, Echelard Y. Production of goats by somatic cell nuclear transfer. Nature Biotechnology, 1999, 17(5): 456–461

[10] Cibelli J B, Stice S L, Golueke P J, Kane J J, Jerry J, Blackwell C, Ponce de León F A, Robl J M. Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science, 1998, 280(5367): 1256–1258

[11] Kato Y, Tani T, Sotomaru Y, Kurokawa K, Kato J, Doguchi H, Yasue H, Tsunoda Y. Eight calves cloned from somatic cells of a single adult. Science, 1998, 282(5396): 2095–2098

[12] Wilmut I, Schnieke A E, McWhir J, Kind A J, Campbell K H S. Viable offspring derived from fetal and adult mammalian cells. Nature, 1997, 385(6619): 810–813

[13] Schnieke A E, Kind A J, Ritchie W A, Mycock K, Scott A R, Ritchie M, Wilmut I, Colman A, Campbell K H S. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science, 1997, 278(5346): 2130–2133

[14] Garas L C, Murray J D, Maga E A. Genetically engineered livestock: ethical use for food and medical models. Annual Review of Animal Biosciences, 2015, 3(1): 559–575

[15] Hsu P D, Lander E S, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell, 2014, 157(6): 1262–1278

[16] Gaj T, Gersbach C A, Barbas C F 3rd. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends in Biotechnology, 2013, 31(7): 397–405

[17] Kawahara A, Hisano Y, Ota S, Taimatsu K. Site-specific integration of exogenous genes using genome editing technologies in zebrafish. International Journal of Molecular Sciences, 2016, 17(5): 727

[18] Campbell K H, McWhir J, Ritchie W A, Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature, 1996, 380(6569): 64–66

[19] Whitelaw C B A, Sheets T P, Lillico S G, Telugu B P. Engineering large animal models of human disease. Journal of Pathology, 2016, 238(2): 247–256

[20] McCreath K J, Howcroft J, Campbell K H S, Colman A, Schnieke A E, Kind A J. Production of gene-targeted sheep by nuclear transfer from cultured somatic cells. Nature, 2000, 405(6790): 1066–1069

[21] San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annual Review of Biochemistry, 2008, 77(1): 229–257

[22] Yu S, Luo J, Song Z, Ding F, Dai Y, Li N. Highly efficient modification of β-lactoglobulin (BLG) gene via zinc-finger nucleases in cattle. Cell Research, 2011, 21(11): 1638–1640

[23] Sun Z, Wang M, Han S, Ma S, Zou Z, Ding F, Li X, Li L, Tang B, Wang H, Li N, Che H, Dai Y. Production of hypoallergenic milk from DNA-free β-lactoglobulin (BLG) gene knockout cow using zinc-finger nucleases mRNA. Scientific Reports, 2018, 8(1): 15430

[24] Ni W, Qiao J, Hu S, Zhao X, Regouski M, Yang M, Polejaeva I A, Chen C. Efficient gene knockout in goats using CRISPR/Cas9 system. PLoS One, 2014, 9(9): e106718

[25] Zhou W, Wan Y, Guo R, Deng M, Deng K, Wang Z, Zhang Y, Wang F. Generation of β-lactoglobulin knock-out goats using CRISPR/Cas9. PLoS One, 2017, 12(10): e0186056

[26] Wei J, Wagner S, Maclean P, Brophy B, Cole S, Smolenski G, Carlson D F, Fahrenkrug S C, Wells D N, Laible G. Cattle with a precise, zygote-mediated deletion safely eliminate the major milk allergen β-lactoglobulin. Scientific Reports, 2018, 8(1): 7661

[27] Liu X, Wang Y, Guo W, Chang B, Liu J, Guo Z, Quan F, Zhang Y. Zinc-finger nickase-mediated insertion of the lysostaphin gene into the β-casein locus in cloned cows. Nature Communications, 2013, 4(1): 2565

[28] Rouet P, Smih F, Jasin M. Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91(13): 6064–6068

[29] Murray J D, Maga E A. Genetically engineered livestock for agriculture: a generation after the first transgenic animal research conference. Transgenic Research, 2016, 25(3): 321–327

[30] Li L, Wu L P, Chandrasegaran S. Functional domains in Fok I restriction endonuclease. Proceedings of the National Academy of Sciences of the United States of America, 1992, 89(10): 4275–4279

[31] Pavletich N P, Pabo C O. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science, 1991, 252(5007): 809–817

[32] Joung J K, Sander J D. TALENs: a widely applicable technology for targeted genome editing. Nature Reviews. Molecular Cell Biology, 2013, 14(1): 49–55

[33] Händel E M, Alwin S, Cathomen T. Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity. Molecular Therapy, 2009, 17(1): 104–111

[34] He J, Li Q, Fang S, Guo Y, Liu T, Ye J, Yu Z, Zhang R, Zhao Y, Hu X, Bai X, Chen X, Li N. PKD1 mono-allelic knockout is sufficient to trigger renal cystogenesis in a mini-pig model. International Journal of Biological Sciences, 2015, 11(4): 361–369

[35] Cui C, Song Y, Liu J, Ge H, Li Q, Huang H, Hu L, Zhu H, Jin Y, Zhang Y. Gene targeting by TALEN-induced homologous recombination in goats directs production of β-lactoglobulin-free, high-human lactoferrin milk. Scientific Reports, 2015, 5(1): 10482

[36] Moore F E, Reyon D, Sander J D, Martinez S A, Blackburn J S, Khayter C, Ramirez C L, Joung J K, Langenau D M. Improved somatic mutagenesis in zebrafish using transcription activator-like effector nucleases (TALENs). PLoS One, 2012, 7(5): e37877

[37] Xiao A, Wu Y, Yang Z, Hu Y, Wang W, Zhang Y, Kong L, Gao G, Zhu Z, Lin S, Zhang B. EENdb: a database and knowledge base of ZFNs and TALENs for endonuclease engineering. Nucleic Acids Research, 2013, 41(Database Issue): D415–D422

[38] Cade L, Reyon D, Hwang W Y, Tsai S Q, Patel S, Khayter C, Joung J K, Sander J D, Peterson R T, Yeh J R J. Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs. Nucleic Acids Research, 2012, 40(16): 8001–8010

[39] Pattanayak V, Ramirez C L, Joung J K, Liu D R. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nature Methods, 2011, 8(9): 765–770

[40] Gabriel R, Lombardo A, Arens A, Miller J C, Genovese P, Kaeppel C, Nowrouzi A, Bartholomae C C, Wang J, Friedman G, Holmes M C, Gregory P D, Glimm H, Schmidt M, Naldini L, von Kalle C. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nature Biotechnology, 2011, 29(9): 816–823

[41] Grau J, Boch J, Posch S. TALENoffer: genome-wide TALEN off-target prediction. Bioinformatics, 2013, 29(22): 2931–2932

[42] Sontheimer E J, Barrangou R. The bacterial origins of the CRISPR genome-editing revolution. Human Gene Therapy, 2015, 26(7): 413–424

[43] Deltcheva E, Chylinski K, Sharma C M, Gonzales K, Chao Y, Pirzada Z A, Eckert M R, Vogel J, Charpentier E. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 2011, 471(7340): 602–607

[44] Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna J A, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012, 337(6096): 816–821

[45] Bolukbasi M F, Gupta A, Wolfe S A. Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nature Methods, 2016, 13(1): 41–50

[46] Cong L, Ran F A, Cox D, Lin S, Barretto R, Habib N, Hsu P D, Wu X, Jiang W, Marraffini L A, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339(6121): 819–823

[47] Mali P, Yang L, Esvelt K M, Aach J, Guell M, DiCarlo J E, Norville J E, Church G M. RNA-guided human genome engineering via Cas9. Science, 2013, 339(6121): 823–826

[48] Ma T, Tao J, Yang M, He C, Tian X, Zhang X, Zhang J, Deng S, Feng J, Zhang Z, Wang J, Ji P, Song Y, He P, Han H, Fu J, Lian Z, Liu G. An AANAT/ASMT transgenic animal model constructed with CRISPR/Cas9 system serving as the mammary gland bioreactor to produce melatonin-enriched milk in sheep. Journal of Pineal Research, 2017, 63(1): e12406

[49] Richt J A, Kasinathan P, Hamir A N, Castilla J, Sathiyaseelan T, Vargas F, Sathiyaseelan J, Wu H, Matsushita H, Koster J, Kato S, Ishida I, Soto C, Robl J M, Kuroiwa Y. Production of cattle lacking prion protein. Nature Biotechnology, 2007, 25(1): 132–138

[50] Denning C, Burl S, Ainslie A, Bracken J, Dinnyes A, Fletcher J, King T, Ritchie M, Ritchie W A, Rollo M, de Sousa P, Travers A, Wilmut I, Clark A J. Deletion of the α(1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheep. Nature Biotechnology, 2001, 19(6): 559–562

[51] Shanthalingam S, Tibary A, Beever J E, Kasinathan P, Brown W C, Srikumaran S. Precise gene editing paves the way for derivation of Mannheimia haemolytica leukotoxin-resistant cattle. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113(46): 13186–13190

[52] Zhang J, Cui M L, Nie Y W, Dai B, Li F R, Liu D J, Liang H, Cang M. CRISPR/Cas9-mediated specific integration of fat-1 at the goat MSTN locus. FEBS Journal, 2018, 285(15): 2828–2839

[53] Zhang Y, Wang Y, Yulin B, Tang B, Wang M, Zhang C, Zhang W, Jin J, Li T, Zhao R, Yu X, Zuo Q, Li B. CRISPR/Cas9-mediated sheep MSTN gene knockout and promote sSMSCs differentiation. Journal of Cellular Biochemistry, 2018, 120(2): 1794–1806

[54] Bertolini L R, Meade H, Lazzarotto C R, Martins L T, Tavares K C, Bertolini M, Murray J D. The transgenic animal platform for biopharmaceutical production. Transgenic Research, 2016, 25(3): 329–343

[55] Houdebine L M. Production of pharmaceutical proteins by transgenic animals. Comparative Immunology, Microbiology and Infectious Diseases, 2009, 32(2): 107–121

[56] Yamasaki M, Sendall T J, Pearce M C, Whisstock J C, Huntington J A. Molecular basis of α1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer. EMBO Reports, 2011, 12(10): 1011–1017

[57] Wang B, Baldassarre H, Tao T, Gauthier M, Neveu N, Zhou J F, Leduc M, Duguay F, Bilodeau A S, Lazaris A, Keefer C, Karatzas C N. Transgenic goats produced by DNA pronuclear microinjection of in vitro derived zygotes. Molecular Reproduction and Development, 2002, 63(4): 437–443

[58] Esslemont D, Kossaibati M. Mastitis: how to get out of the dark ages. Veterinary Journal, 2002, 164(2): 85–86

[59] Rainard P. Tackling mastitis in dairy cows. Nature Biotechnology, 2005, 23(4): 430–432

[60] Wall R J, Powell A M, Paape M J, Kerr D E, Bannerman D D, Pursel V G, Wells K D, Talbot N, Hawk H W. Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nature Biotechnology, 2005, 23(4): 445–451

[61] Oldham E R, Daley M J. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic. Journal of Dairy Science, 1991, 74(12): 4175–4182

[62] Lloyd S E, Mead S, Collinge J. Genetics of prion diseases. Current Opinion in Genetics & Development, 2013, 23(3): 345–351

[63] Wells G A, Scott A C, Johnson C T, Gunning R F, Hancock R D, Jeffrey M, Dawson M, Bradley R. A novel progressive spongiform encephalopathy in cattle. Veterinary Record, 1987, 121(18): 419–420

[64] Jeffrey M, González L. Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease. Neuropathology and Applied Neurobiology, 2007, 33(4): 373–394

[65] Aguilar-Calvo P, García C, Espinosa J C, Andreoletti O, Torres J M. Prion and prion-like diseases in animals. Virus Research, 2015, 207: 82–93

[66] Prusiner S B, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang S L, DeArmond S J. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proceedings of the National Academy of Sciences of the United States of America, 1993, 90(22): 10608–10612

[67] Breider M A, Walker R D, Hopkins F M, Schultz T W, Bowersock T L. Pulmonary lesions induced by Pasteurella haemolytica in neutrophil sufficient and neutrophil deficient calves. Canadian Journal of Veterinary Research, 1988, 52(2): 205–209

[68] Mueller M L, Cole J B, Sonstegard T S, Van Eenennaam A L. Comparison of gene editing versus conventional breeding to introgress the POLLED allele into the US dairy cattle population. Journal of Dairy Science, 2019, 102(5): 4215–4226

[69] Regalado A. Gene-edited cattle have a major screwup in their DNA. MIT Technology Review, 2019 [Published Online] https://www.technologyreview.com/s/614235/recombinetics-gene-edited-hornless-cattle-major-dna-screwup/

[70] Norris L A, Lee S S, Greenlees K J, Tadesse D A, Miller M F, Lombard H. Template plasmid integration in germline genome-edited cattle. BioRxiv, 2019 [Published Online] doi:10.1101/715482

[71] Kleinstiver B P, Pattanayak V, Prew M S, Tsai S Q, Nguyen N T, Zheng Z, Joung J K. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature, 2016, 529(7587): 490–495

[72] Slaymaker I M, Gao L, Zetsche B, Scott D A, Yan W X, Zhang F. Rationally engineered Cas9 nucleases with improved specificity. Science, 2016, 351(6268): 84–88

[73] Tsai S Q, Nguyen N T, Malagon-Lopez J, Topkar V V, Aryee M J, Joung J K. CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets. Nature Methods, 2017, 14(6): 607–614

[74] Tsai S Q, Zheng Z, Nguyen N T, Liebers M, Topkar V V, Thapar V, Wyvekens N, Khayter C, Iafrate A J, Le L P, Aryee M J, Joung J K. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nature Biotechnology, 2015, 33(2): 187–197

[75] Ehn B M, Ekstrand B, Bengtsson U, Ahlstedt S. Modification of IgE binding during heat processing of the cow’s milk allergen β-lactoglobulin. Journal of Agricultural and Food Chemistry, 2004, 52(5): 1398–1403

[76] Ehn B M, Allmere T, Telemo E, Bengtsson U, Ekstrand B. Modification of IgE binding to β-lactoglobulin by fermentation and proteolysis of cow’s milk. Journal of Agricultural and Food Chemistry, 2005, 53(9): 3743–3748

[77] Grobet L, Martin L J, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Ménissier F, Massabanda J, Fries R, Hanset R, Georges M. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nature Genetics, 1997, 17(1): 71–74

[78] Dove A. Milking the genome for profit. Nature Biotechnology, 2000, 18(10): 1045–1048

[79] Brophy B, Smolenski G, Wheeler T, Wells D, L’Huillier P, Laible G. Cloned transgenic cattle produce milk with higher levels of β-casein and κ-casein. Nature Biotechnology, 2003, 21(2): 157–162

[80] Colman A. Somatic cell nuclear transfer in mammals: progress and applications. Cloning, 1999–2000, 1(4): 185–200

[81] Zhang J P, Li X L, Li G H, Chen W, Arakaki C, Botimer G D, Baylink D, Zhang L, Wen W, Fu Y W, Xu J, Chun N, Yuan W, Cheng T, Zhang X B. Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage. Genome Biology, 2017, 18(1): 35

[82] Song J, Yang D, Xu J, Zhu T, Chen Y E, Zhang J. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency. Nature Communications, 2016, 7(1): 10548

[83] Kipriyanov S M, Moldenhauer G, Braunagel M, Reusch U, Cochlovius B, Le Gall F, Kouprianova O A, Von der Lieth C W, Little M. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies. Journal of Molecular Biology, 2003, 330(1): 99–111

[84] Little M, Kipriyanov S M, Le Gall F, Moldenhauer G. Of mice and men: hybridoma and recombinant antibodies. Immunology Today, 2000, 21(8): 364–370

[85] Walsh G. Biopharmaceutical benchmarks 2014. Nature Biotechnology, 2014, 32(10): 992–1000

[86] Grosse-Hovest L, Müller S, Minoia R, Wolf E, Zakhartchenko V, Wenigerkind H, Lassnig C, Besenfelder U, Müller M, Lytton S D, Jung G, Brem G. Cloned transgenic farm animals produce a bispecific antibody for T cell-mediated tumor cell killing. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101(18): 6858–6863

[87] Fan Z, Perisse I V, Cotton C U, Regouski M, Meng Q, Domb C, Van Wettere A J, Wang Z, Harris A, White K L, Polejaeva I A. A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene. JCI Insight, 2018, 3(19): e123529

[88] Williams D K, Pinzón C, Huggins S, Pryor J H, Falck A, Herman F, Oldeschulte J, Chavez M B, Foster B L, White S H, Westhusin M E, Suva L J, Long C R, Gaddy D. Genetic engineering a large animal model of human hypophosphatasia in sheep. Scientific Reports, 2018, 8(1): 16945

[89] Du S J, Gong Z Y, Fletcher G L, Shears M A, King M J, Idler D R, Hew C L. Growth enhancement in transgenic Atlantic salmon by the use of an “all fish” chimeric growth hormone gene construct. Bio-Technology, 1992, 10(2): 176–181

[90] Kling J. First US approval for a transgenic animal drug. Nature Biotechnology, 2009, 27(4): 302–304

[91] van Veen H A, Koiter J, Vogelezang C J M, van Wessel N, van Dam T, Velterop I, van Houdt K, Kupers L, Horbach D, Salaheddine M, Nuijens J H, Mannesse M L M. Characterization of recombinant human C1 inhibitor secreted in milk of transgenic rabbits. Journal of Biotechnology, 2012, 162(2–3): 319–326

[92] Sheridan C. FDA approves ‘farmaceutical’ drug from transgenic chickens. Nature Biotechnology, 2016, 34(2): 117–119

[93] Bruce A. Genome edited animals: learning from GM crops? Transgenic Research, 2017, 26(3): 385–398

[94] Ishii T. Genome-edited livestock: ethics and social acceptance. Animal Frontiers, 2017, 7(2): 24–32

[95] Schicktanz S. Ethical considerations of the human-animal-relationship under conditions of asymmetry and ambivalence. Journal of Agricultural & Environmental Ethics, 2006, 19(1): 7–16

Acknowledgements

This work was supported by the National Major Project for Production of Transgenic Breeding (2016ZX08007003). We thank the FASE team for editing the English draft of this manuscript.

Compliance with ethics guidelines

Mengke Yuan, Yuanpeng Gao, Jing Han, Teng Wu, Jingcheng Zhang, Yongke Wei, and Yong Zhang declare that they have no conflicts of interest or financial conflicts to disclose.

This article is a review and does not contain any studies with human or animal subjects performed by any of the authors.

RIGHTS & PERMISSIONS

The Author(s) 2019. Published by Higher Education Press. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0)